1.
Emaran Sheikh Ismail TS, Bhangale C, Ramanand J, Mahajan H. Clinical outcome and toxicity in post-COVID suspected cases of mucormycosis treated with amphotericin B at dedicated COVID hospital: a prospective observational study. Int J Basic Clin Pharmacol [Internet]. 2021 Oct. 22 [cited 2025 Oct. 23];10(11):1271-5. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/4827